Patient acceptable symptom state in scleroderma: Results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis
Michael B. Arnold, Dinesh Khanna, Christopher P. Denton, Jacob M. van Laar, Tracy M. Frech, Marina E. Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan, Yannick Allanore, Gabriela Riemekasten, Virginia Steen, Ulf Müller-Ladner, Helen Spotswood, Laura Burke, Jeffrey Siegel, Angelika Jahreis, Daniel E. Furst, Janet E. Pope*
*Korrespondierende/r Autor/-in für diese Arbeit
- University of Michigan
- University College London
- Utrecht University
- University of Utah
- University of Liverpool
- McGill University
- Stanford University
- Eberhard Karls Universität Tübingen
- University of Connecticut Health Center
- Universität Paris V
- Georgetown University
- Justus-Liebig-Universität Gießen
- Roche Products Ltd
- Genentech Incorporated
- University of California, Los Angeles
17
Link öffnet neuen Tab
Zitate (Scopus)